Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant

Overview of attention for article published in British Journal of Haematology, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#37 of 8,179)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 14 news stories from 14 outlets.

(HealthDay News) — Younger adults with multiple myeloma (MM) who receive an autologous transplant upfront have durable survival…

By Lori Solomon HealthDay Reporter THURSDAY, July 27, 2023 -- Younger adults with newly diagnosed multiple myeloma who receive…

Younger adults with newly diagnosed multiple myeloma who receive an autologous stem cell transplant (auto-HCT) have a median…

THURSDAY, July 27, 2023 (HealthDay News) -- Younger adults with newly diagnosed multiple myeloma who receive an autologous stem…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 10 additional news stories.